Pharmacogenetic discovery in CALGB (alliance) 90401 and mechanistic validation of a VAC14 polymorphism that increases risk of docetaxel-induced neuropathy Academic Article uri icon

Overview

MeSH Major

  • Antigens, Surface
  • Biomarkers, Tumor
  • Carcinoma, Renal Cell
  • Glutamate Carboxypeptidase II
  • Kidney Neoplasms

abstract

  • VAC14 should be prioritized for further validation of its potential role as a predictor of docetaxel-induced neuropathy and biomarker for treatment individualization. Clin Cancer Res; 22(19); 4890-900. ©2016 AACR.

authors

publication date

  • October 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5050068

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-15-2823

PubMed ID

  • 27143689

Additional Document Info

start page

  • 4890

end page

  • 4900

volume

  • 22

number

  • 19